Dipeptidyl Peptidase-4 Inhibition May Stimulate Progression of Carcinoid Tumor

Dipeptidyl peptidase-4 (DPP-4) inhibitors, such as saxagliptin, have gained a rapid growth in use in the treatment of type 2 diabetes mellitus in the past decade. Although they are considered to have a good safety profile, controversy exists regarding their potential to stimulate neoplasm growth. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Pech, Vladimir, Abusaada, Khalid, Alemany, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531174/
https://www.ncbi.nlm.nih.gov/pubmed/26290759
http://dx.doi.org/10.1155/2015/952019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531174/
https://www.ncbi.nlm.nih.gov/pubmed/26290759
http://dx.doi.org/10.1155/2015/952019

Ejemplares similares